Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis

被引:2
|
作者
Wang, Saikun [1 ]
Zhu, Ruiting [1 ]
Zhang, Chengwei [2 ]
Guo, Yingze [1 ]
Lv, Mengjiao [1 ]
Zhang, Changyue [1 ]
Bian, Ce [1 ]
Jiang, Ruixue [1 ]
Zhou, Wei [3 ]
Guo, Lirong [1 ]
机构
[1] Jilin Univ, Sch Nursing, Changchun, Jilin, Peoples R China
[2] Second Hosp Jilin Univ, Dept Anesthesiol, Changchun, Jilin, Peoples R China
[3] First Hosp Jilin Univ, Changchun, Jilin, Peoples R China
来源
PLOS ONE | 2023年 / 18卷 / 10期
关键词
CRITICALLY-ILL PATIENTS; CLINICAL CHARACTERISTICS; MYOCARDIAL INJURY; CRITICAL ILLNESS; MORTALITY; SEVERITY; OUTCOMES; DEATH; PREDICTORS; SARS-COV-2;
D O I
10.1371/journal.pone.0292021
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although studies have shown severe Coronavirus disease 2019 (COVID-19) outcomes in patients with pre-existing coronary heart disease (CHD), the prognosis of COVID-19 patients with pre-existing CHD remains uncertain primarily due to the limited number of patients in existing studies. This study aimed to investigate the impacts of pre-existing CHD on the prognosis of COVID-19 patients. Five electronic databases were searched for eligible studies. This article focused on cohort and case-control studies involving the prognosis of COVID-19 patients with pre-existing CHD. The meta-analysis was performed using a random effects model. The odds ratios (ORs) and 95% confidence intervals (CIs) were used as valid indicators. The study was registered in PROSPERO with the identifier: CRD42022352853. A total of 81 studies, involving 157,439 COVID-19 patients, were included. The results showed that COVID-19 patients with pre-existing CHD exhibited an elevated risk of mortality (OR = 2.45; 95%CI: [2.04, 2.94], P < 0.001), severe/critical COVID-19 (OR = 2.57; 95%CI: [1.98, 3.33], P < 0.001), Intensive Care Unit or Coronary Care Unit (ICU/CCU) admission: (OR = 2.75, 95%CI: [1.61, 4.72], P = 0.002), and reduced odds of discharge/recovery (OR = 0.43, 95%CI: [0.28, 0.66], P < 0.001) compared to COVID-19 patients without pre-existing CHD. Subgroup analyses indicated that the prognosis of COVID-19 patients with pre-existing CHD was influenced by publication year, follow-up duration, gender, and hypertension. In conclusion, pre-existing CHD significantly increases the risk of poor prognosis in patients with COVID-19, particularly in those male or hypertensive patients.
引用
收藏
页数:22
相关论文
共 50 条
  • [31] Incidence and prognosis of COVID-19 amongst heart transplant recipients: a systematic review and meta-analysis
    Ahmed, Furqan
    Abid, Minaam
    Maniya, Talha
    Usman, Muhammad Shariq
    Fudim, Marat
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (06) : E224 - E226
  • [32] A systematic review and meta-analysis on the prevalence and impact of coronary artery disease in hospitalized COVID-19 patients
    Merzah, Mohammed A.
    Sulaiman, Dahy
    Abul Karim, Atiya
    Khalil, Mazin E.
    Gupta, Sabyasachi
    Almuzaini, Yasir
    Hashemi, Shima
    Mathew, Stany
    Khatoon, Salina
    Hoque, Mohima Benojir
    HELIYON, 2023, 9 (09)
  • [33] COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS
    Tripathi, Kartikeya
    Brewer, Gala Godoy
    Minh Thu Nguyen
    Singh, Yuvaraj
    Ismail, Mohamed Saleh
    Sauk, Jenny S.
    Parian, Alyssa M.
    Limketkai, Berkeley N.
    GASTROENTEROLOGY, 2021, 160 (06) : S333 - S333
  • [34] Antirheumatic Disease Therapies in Patients with COVID-19: A Systematic Review and Meta-analysis
    Putman, Michael
    Chock, Yu Pei Eugenia
    Tam, Herman
    Kim, Alfred
    Sattui, Sebastian
    Berenbaum, Francis
    Danila, Maria
    Korsten, Peter
    Alvarez, Catalina Sanchez
    Sparks, Jeffrey
    Coates, Laura
    Palmerlee, Candace
    Pierce, Andrea
    Jayatilleke, Arundathi
    Johnson, Sindhu
    Kilian, Adam
    Liew, Jean
    Prokop, Larry
    Murad, Hassan
    Grainger, Rebecca
    Wallace, Zachary
    Duarte-Garcia, Ali
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [35] Impact of COVID-19 on pre-existing liver disease
    Abdo-Francis, Juan M.
    Moreno-Alcantar, Rosalba
    Perez-Hernandez, Jose L.
    Remes-Troche, Jose M.
    Velasco, Antonio Velarde-Ruiz
    Cerda-Reyes, Eira
    de la Tijera, Fatima Higuera
    Castro-Narro, Graciela
    CIRUGIA Y CIRUJANOS, 2024, 92 (01): : 131 - 136
  • [36] The Effects Of Breathing Exercises On Patients With Covid-19: A Systematic Review And Meta-analysis
    Pi, Peng
    Zeng, Liqing
    Wang, Yan
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2024, 56 (10) : 728 - 728
  • [37] Effects of underlying heart failure on outcomes of COVID-19; a systematic review and meta-analysis
    Morsali, Soroush
    Rezazadeh-Gavgani, Erfan
    Oladghaffari, Mobina
    Bahramian, Shirin
    Hamzehzadeh, Sina
    Samadifar, Zahra
    Enamzadeh, Elgar
    Sheikhalipour, Zahra
    Moradi, Haniyeh
    Pourmehr, Hanieh Salehi
    Naseri, Amirreza
    Taban-Sadeghi, Mohammadreza
    Daneshvar, Sara
    ROMANIAN JOURNAL OF INTERNAL MEDICINE, 2023, 61 (01) : 6 - 27
  • [38] Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence
    Treskova-Schwarzbach, Marina
    Haas, Laura
    Reda, Sarah
    Pilic, Antonia
    Borodova, Anna
    Karimi, Kasra
    Koch, Judith
    Nygren, Teresa
    Scholz, Stefan
    Schoenfeld, Viktoria
    Vygen-Bonnet, Sabine
    Wichmann, Ole
    Harder, Thomas
    BMC MEDICINE, 2021, 19 (01)
  • [39] A Retrospective Analysis of Azvudine in Patients with COVID-19 and Pre-existing Cancer
    Li, Fangyu
    Zheng, Keao
    Qi, Xueyan
    Cui, Kaixia
    Yang, Jing
    Hao, Zhiying
    JOURNAL OF CANCER, 2024, 15 (08): : 2442 - 2447
  • [40] Coagulopathy in patients with COVID-19: a systematic review and meta-analysis
    Zhang, Xiaolin
    Yang, Xue
    Jiao, Hongmei
    Liu, Xinmin
    AGING-US, 2020, 12 (24): : 24535 - 24551